Terug
Dagbereik
€ 4,14
€ 4,50
52-Weeksbereik
€ 2,28
€ 4,59
Volume
600
50D / 200D Gem.
€ 4,44
/
€ 3,49
Vorige Slotkoers
€ 4,44
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,4 | 0,3 |
| P/B | — | 3,0 |
| ROE % | — | 3,7 |
| Net Margin % | -1251,1 | 3,8 |
| Rev Growth 5Y % | 150,8 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
-€ 0,11
-€ 0,11 – -€ 0,11
|
257,70M | 4 |
| FY2028 |
-€ 0,55
-€ 0,55 – -€ 0,55
|
96,36M | 3 |
| FY2027 |
-€ 0,67
-€ 0,67 – -€ 0,67
|
25,05M | 2 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 150,82% annually over 5 years — strong growth
Negative free cash flow of -86,26M
Revenue growth is decelerating — 1Y growth trails 5Y average by 166,57%
Capital efficient — spends only 2,26% of revenue on capex
Groei
Revenue Growth (5Y)
150,82%
Revenue (1Y)-15,75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-1251,10%
Op. Margin-662,58%
Veiligheid
Debt / Equity
N/A
Current Ratio0,92
Interest Coverage-8,01
Waardering
P/E Ratio
-3,35
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -15,75% | Revenue Growth (3Y) | 9,95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 150,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14,72M | Net Income (TTM) | -184,21M |
| ROE | N/A | ROA | -154,84% |
| Gross Margin | 62,47% | Operating Margin | -662,58% |
| Net Margin | -1251,10% | Free Cash Flow (TTM) | -86,26M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,92 |
| Interest Coverage | -8,01 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,35 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 41,93 |
| PEG Ratio | -0,04 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -13,97% | ||
| Market Cap | 617,43M | Enterprise Value | 575,20M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 14,72M | 17,48M | 12,18M | 4,19M | 372.000,0 |
| Net Income | -184,21M | -110,43M | -54,27M | -49,64M | -31,62M |
| EPS (Diluted) | -3,08 | -2,43 | -1,31 | -1,27 | -0,93 |
| Gross Profit | 9,20M | 17,50M | 11,18M | 3,18M | -474.000,0 |
| Operating Income | -97,56M | -102,71M | -57,11M | -52,11M | -29,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 118,97M | 69,56M | 116,00M | 121,99M | 138,92M |
| Total Liabilities | 225,61M | 101,59M | 70,53M | 33,12M | 27,71M |
| Shareholders' Equity | -106,65M | -32,03M | 45,48M | 88,87M | 111,21M |
| Total Debt | 54,33M | 37,49M | 34,51M | 10,12M | 13,25M |
| Cash & Equivalents | 96,56M | 26,92M | 86,74M | 86,55M | 105,69M |
| Current Assets | 111,51M | 48,19M | 106,38M | 115,58M | 133,00M |
| Current Liabilities | 120,73M | 50,16M | 30,70M | 22,85M | 13,91M |